Maria Ines Mitrani, Chief Science Officer at Organicell Regenerative Medicine, Inc. (BPSR), sold 175,000 shares at $0.22 ($41K) on 2021-05-17, disclosed to the SEC on 2021-05-17.
Open-market sale of $41k BPSR by Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.27 | 50,000 | $14K | 32.9% |
| 2 | $0.24 | 50,000 | $12K | 29.3% |
| 3 | $0.20 | 25,000 | $5K | 12.2% |
| 4 | $0.21 | 49,700 | $10K | 25.5% |
| 5 | $0.22 | 300 | $66 | 0.2% |
| Total | $0.23 avg | 175,000 |
| $41K |
| 100% |
| Filing → |
| BPSR | SELL | 2021-06-11 | $31K | — | Filing → |
| BPSR | SELL | 2021-06-08 | $34K | — | Filing → |
| BPSR | SELL | 2021-06-03 | $24K | — | Filing → |